Published in Mol Pain on March 02, 2010
Targeting the overproduction of peroxynitrite for the prevention and reversal of paclitaxel-induced neuropathic pain. J Neurosci (2012) 1.21
Genetic variations in interleukin-8 and interleukin-10 are associated with pain, depressed mood, and fatigue in lung cancer patients. J Pain Symptom Manage (2012) 0.96
Valproic acid: an anticonvulsant drug with potent antinociceptive and anti-inflammatory properties. Naunyn Schmiedebergs Arch Pharmacol (2013) 0.87
Spinal mitochondrial-derived peroxynitrite enhances neuroimmune activation during morphine hyperalgesia and antinociceptive tolerance. Pain (2013) 0.84
Small molecule inhibitors of PSD95-nNOS protein-protein interactions as novel analgesics. Neuropharmacology (2015) 0.83
Fat Grafting in Burn Scar Alleviates Neuropathic Pain via Anti-Inflammation Effect in Scar and Spinal Cord. PLoS One (2015) 0.82
Effects of treatment with a carbon monoxide-releasing molecule and a heme oxygenase 1 inducer in the antinociceptive effects of morphine in different models of acute and chronic pain in mice. Psychopharmacology (Berl) (2013) 0.81
β2- and β3-adrenergic receptors drive COMT-dependent pain by increasing production of nitric oxide and cytokines. Pain (2014) 0.81
Sucrose-induced analgesia in mice: role of nitric oxide and opioid receptor-mediated system. Indian J Pharmacol (2013) 0.79
The three isoforms of nitric oxide synthase distinctively affect mouse nocifensive behavior. Nitric Oxide (2011) 0.79
Effects of pentoxifylline, 7-nitroindazole, and imipramine on tumor necrosis factor-α and indoleamine 2,3-dioxygenase enzyme activity in the hippocampus and frontal cortex of chronic mild-stress-exposed rats. Neuropsychiatr Dis Treat (2013) 0.78
Impaired behavioural pain responses in hph-1 mice with inherited deficiency in GTP cyclohydrolase 1 in models of inflammatory pain. Mol Pain (2013) 0.77
Treatment with a carbon monoxide-releasing molecule inhibits chronic inflammatory pain in mice: nitric oxide contribution. Psychopharmacology (Berl) (2013) 0.76
The role of nitric oxide on the oxytocin induce analgesia in mice. Iran J Basic Med Sci (2016) 0.76
Neuronal activation and plasticity in Schistosoma mansoni infected mice. Saudi J Biol Sci (2012) 0.75
Nitric oxide modulates the hyperalgesic response to mechanical noxious stimuli in sleep-deprived rats. BMC Neurosci (2013) 0.75
Effects of inducible nitric oxide synthase blockade within the periaqueductal gray on cardiovascular responses during mechanical, heat, and cold nociception. Neurol Sci (2011) 0.75
The role of the transient receptor potential ankyrin type-1 (TRPA1) channel in migraine pain: evaluation in an animal model. J Headache Pain (2017) 0.75
Affective and cognitive behavior in the alpha-galactosidase A deficient mouse model of Fabry disease. PLoS One (2017) 0.75
Effects of chronic nitric oxide synthase inhibition on V'O2max and exercise capacity in mice. Naunyn Schmiedebergs Arch Pharmacol (2016) 0.75
A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain (1988) 18.17
Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature (1995) 9.86
Targeted disruption of the neuronal nitric oxide synthase gene. Cell (1993) 5.02
Mice lacking inducible nitric oxide synthase are not resistant to lipopolysaccharide-induced death. Proc Natl Acad Sci U S A (1995) 3.53
The pivotal role of tumour necrosis factor alpha in the development of inflammatory hyperalgesia. Br J Pharmacol (1992) 3.21
Nitric oxide and superoxide in inflammation and immune regulation. J Physiol Pharmacol (2003) 2.89
Tumor necrosis factor-alpha induces mechanical allodynia after spinal nerve ligation by activation of p38 MAPK in primary sensory neurons. J Neurosci (2003) 2.89
Nitric oxide (NO) and nociceptive processing in the spinal cord. Pain (1993) 2.82
Interleukin-1 beta as a potent hyperalgesic agent antagonized by a tripeptide analogue. Nature (1988) 2.72
Cytokines, nerve growth factor and inflammatory hyperalgesia: the contribution of tumour necrosis factor alpha. Br J Pharmacol (1997) 2.59
Neuronal plasticity and signal transduction in nociceptive neurons: implications for the initiation and maintenance of pathological pain. Neurobiol Dis (2001) 2.49
Selective pharmacological inhibition of distinct nitric oxide synthase isoforms. Biochem Pharmacol (1996) 2.48
Hypernociceptive role of cytokines and chemokines: targets for analgesic drug development? Pharmacol Ther (2006) 2.13
Contribution of interleukin-1 beta to the inflammation-induced increase in nerve growth factor levels and inflammatory hyperalgesia. Br J Pharmacol (1995) 2.12
Inflammatory pain hypersensitivity mediated by phenotypic switch in myelinated primary sensory neurons. Nature (1996) 1.94
A nitric oxide signaling pathway controls CREB-mediated gene expression in neurons. Mol Cell (2006) 1.75
Mechanisms of inflammatory pain. Br J Anaesth (2001) 1.75
Controlling pathological pain by adenovirally driven spinal production of the anti-inflammatory cytokine, interleukin-10. Eur J Neurosci (2005) 1.73
Intrathecal interleukin-10 gene therapy attenuates paclitaxel-induced mechanical allodynia and proinflammatory cytokine expression in dorsal root ganglia in rats. Brain Behav Immun (2006) 1.67
The possible role of glia in nociceptive processing and hyperalgesia in the spinal cord of the rat. Neuropharmacology (1994) 1.51
Isoforms of nitric oxide synthase. Properties, cellular distribution and expressional control. Biochem Pharmacol (1995) 1.42
Selective inhibition of constitutive nitric oxide synthase by L-NG-nitroarginine. Biochemistry (1993) 1.35
Inhibition of p38 mitogen-activated protein kinase attenuates interleukin-1beta-induced thermal hyperalgesia and inducible nitric oxide synthase expression in the spinal cord. J Neurochem (2005) 1.34
T cell infiltration after chronic constriction injury of mouse sciatic nerve is associated with interleukin-17 expression. Exp Neurol (2006) 1.30
Effect of genetic knockout or pharmacologic inhibition of neuronal nitric oxide synthase on complete Freund's adjuvant-induced persistent pain. Pain (2005) 1.29
Effects of interleukin-10 (IL-10) on pain behavior and gene expression following excitotoxic spinal cord injury in the rat. Exp Neurol (2001) 1.29
Nitric oxide signaling in pain and nociceptor sensitization in the rat. J Neurosci (1998) 1.28
Spinal nitric oxide synthesis inhibition blocks NMDA-induced thermal hyperalgesia and produces antinociception in the formalin test in rats. Pain (1993) 1.26
Differential roles of neuronal and endothelial nitric oxide synthases during carrageenan-induced inflammatory hyperalgesia. Neuroscience (2004) 1.21
Anti-inflammatory interleukin-10 therapy in CCI neuropathy decreases thermal hyperalgesia, macrophage recruitment, and endoneurial TNF-alpha expression. Pain (1998) 1.18
Dynamic regulation of the proinflammatory cytokine, interleukin-1beta: molecular biology for non-molecular biologists. Life Sci (1999) 1.14
HIV-1 gp120 stimulates proinflammatory cytokine-mediated pain facilitation via activation of nitric oxide synthase-I (nNOS). Pain (2004) 1.13
Nitric oxide synthase in spinal cord central sensitization following intradermal injection of capsaicin. Pain (2001) 1.09
Intact carrageenan-induced thermal hyperalgesia in mice lacking inducible nitric oxide synthase. Neuroscience (2003) 1.08
The extent of cytokine induction in peripheral nerve lesions depends on the mode of injury and NMDA receptor signaling. J Neuroimmunol (2004) 1.08
Cytokine regulation in animal models of neuropathic pain and in human diseases. Neurosci Lett (2008) 1.06
Differences in inflammatory pain in nNOS-, iNOS- and eNOS-deficient mice. Eur J Pain (2007) 1.05
Effects of intrathecal administration of nitric oxide synthase inhibitors on carrageenan-induced thermal hyperalgesia. Br J Pharmacol (1999) 1.04
Intrathecal interleukin-1beta administration induces thermal hyperalgesia by activating inducible nitric oxide synthase expression in the rat spinal cord. Brain Res (2004) 1.02
Intracellular HIV-Tat expression induces IL-10 synthesis by the CREB-1 transcription factor through Ser133 phosphorylation and its regulation by the ERK1/2 MAPK in human monocytic cells. J Biol Chem (2006) 1.02
Induction of spinal cord neuronal nitric oxide synthase (NOS) after formalin injection in the rat hind paw. Neurosci Lett (1996) 1.01
Antinociceptive activity of the selective iNOS inhibitor AR-C102222 in rodent models of inflammatory, neuropathic and post-operative pain. Eur J Pain (2005) 0.98
Purification and characterization of the constitutive nitric oxide synthase from human placenta. Arch Biochem Biophys (1994) 0.98
Effects of selective inhibitors of neuronal nitric oxide synthase on carrageenan-induced mechanical and thermal hyperalgesia. Neuropharmacology (1998) 0.97
Nitric oxide in the central nervous system. Ann Med (1995) 0.96
Role of nitric oxide in the regulation of acute and chronic inflammation. Antioxid Redox Signal (2000) 0.96
The role of nitric oxide in nociception. Curr Rev Pain (2000) 0.95
Inhibition of spinal constitutive NOS-2 by 1400W attenuates tissue injury and inflammation-induced hyperalgesia and spinal p38 activation. Eur J Neurosci (2007) 0.95
Transcriptional regulation of the tumor necrosis factor alpha gene. Immunobiology (1995) 0.90
The role of nitric oxide in spinal nociceptive reflexes in rats with neurogenic and non-neurogenic peripheral inflammation. Neuropharmacology (1994) 0.86
Activation of the nociceptin opioid system in rat sensory neurons produces antinociceptive effects in inflammatory pain: involvement of inflammatory mediators. J Neurosci Res (2007) 0.83
Interleukin-10 reduces hyperalgesia and the level of Interleukin-1beta in BALB/c mice infected with Leishmania major with no major effect on the level of Interleukin-6. J Neuroimmunol (2006) 0.81
Increased production of nitric oxide stimulated by interferon-gamma from peripheral blood monocytes in patients with complex regional pain syndrome. Neurosci Lett (2002) 0.81
Intrathecal interferon-gamma facilitates the spinal nociceptive flexor reflex in the rat. Neurosci Lett (1994) 0.80
Analysis of leukotriene receptor antagonists on isolated human intralobar airways. Ann N Y Acad Sci (1988) 0.77
Inflammatory pain: the role of cytokines and its control by drugs which release nitric oxide. Ann Ist Super Sanita (1993) 0.76
Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet (2013) 8.02
NeuPSIG guidelines on neuropathic pain assessment. Pain (2010) 4.04
Reduced dermal nerve fiber diameter in skin biopsies of patients with fibromyalgia. Pain (2015) 3.82
Meta-analysis of genome-wide association studies of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry (2010) 3.13
Tumor necrosis factor-alpha induces mechanical allodynia after spinal nerve ligation by activation of p38 MAPK in primary sensory neurons. J Neurosci (2003) 2.89
Small fibre pathology in patients with fibromyalgia syndrome. Brain (2013) 2.72
Genome-wide association study identifies genetic variation in neurocan as a susceptibility factor for bipolar disorder. Am J Hum Genet (2011) 2.71
Genome-wide analysis of copy number variants in attention deficit hyperactivity disorder: the role of rare variants and duplications at 15q13.3. Am J Psychiatry (2012) 2.48
Molecular genetics of adult ADHD: converging evidence from genome-wide association and extended pedigree linkage studies. J Neural Transm (Vienna) (2008) 2.43
Stiff person syndrome-associated autoantibodies to amphiphysin mediate reduced GABAergic inhibition. Brain (2010) 2.35
Neurofascin as a target for autoantibodies in peripheral neuropathies. Neurology (2012) 2.09
Treatment of fibromyalgia syndrome with gabapentin and pregabalin--a meta-analysis of randomized controlled trials. Pain (2009) 1.93
Chronically infused intrathecal morphine in dogs. Anesthesiology (2003) 1.93
Differential expression patterns of cytokines in complex regional pain syndrome. Pain (2007) 1.91
Case-control genome-wide association study of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry (2010) 1.86
Human Stiff person syndrome IgG-containing high-titer anti-GAD65 autoantibodies induce motor dysfunction in rats. Exp Neurol (2012) 1.81
TNF-α in CRPS and 'normal' trauma--significant differences between tissue and serum. Pain (2010) 1.74
Reduced levels of antiinflammatory cytokines in patients with chronic widespread pain. Arthritis Rheum (2006) 1.64
Genome-wide copy number variation study associates metabotropic glutamate receptor gene networks with attention deficit hyperactivity disorder. Nat Genet (2011) 1.63
Functional and structural nerve fiber findings in heterozygote patients with Fabry disease. Pain (2009) 1.62
Treatment of fibromyalgia syndrome with antidepressants: a meta-analysis. JAMA (2009) 1.58
Local cytokine changes in complex regional pain syndrome type I (CRPS I) resolve after 6 months. Pain (2013) 1.52
TRESK two-pore-domain K+ channels constitute a significant component of background potassium currents in murine dorsal root ganglion neurones. J Physiol (2007) 1.51
Meta-analysis of genome-wide linkage scans of attention deficit hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet (2008) 1.48
Chronic inflammatory demyelinating polyradiculoneuropathy: diagnostic and therapeutic challenges for a treatable condition. Lancet Neurol (2010) 1.41
Intravenous immunoglobulin to fight complex regional pain syndromes: hopes and doubts. Ann Intern Med (2010) 1.38
Differential expression of cytokines in painful and painless neuropathies. Neurology (2007) 1.38
A key role for gp130 expressed on peripheral sensory nerves in pathological pain. J Neurosci (2009) 1.37
Deficiency of brain 5-HT synthesis but serotonergic neuron formation in Tph2 knockout mice. J Neural Transm (Vienna) (2008) 1.36
Multicenter analysis of the SLC6A3/DAT1 VNTR haplotype in persistent ADHD suggests differential involvement of the gene in childhood and persistent ADHD. Neuropsychopharmacology (2009) 1.33
Selective increase of tumour necrosis factor-alpha in injured and spared myelinated primary afferents after chronic constrictive injury of rat sciatic nerve. Eur J Neurosci (2003) 1.32
Activation of TRPV1 contributes to morphine tolerance: involvement of the mitogen-activated protein kinase signaling pathway. J Neurosci (2008) 1.31
T cell infiltration after chronic constriction injury of mouse sciatic nerve is associated with interleukin-17 expression. Exp Neurol (2006) 1.30
Systematic review with meta-analysis: cytokines in fibromyalgia syndrome. BMC Musculoskelet Disord (2011) 1.30
Joint pain. Exp Brain Res (2009) 1.29
Mode of action of cytokines on nociceptive neurons. Exp Brain Res (2009) 1.26
Spatio-temporal expression of tryptophan hydroxylase isoforms in murine and human brain: convergent data from Tph2 knockout mice. Eur Neuropsychopharmacol (2009) 1.22
Small fibers in Fabry disease: baseline and follow-up data under enzyme replacement therapy. J Peripher Nerv Syst (2011) 1.15
Comparative efficacy and harms of duloxetine, milnacipran, and pregabalin in fibromyalgia syndrome. J Pain (2010) 1.15
Intramuscular injection of tumor necrosis factor-alpha induces muscle hyperalgesia in rats. Pain (2003) 1.15
Wallerian degeneration after crush injury of rat sciatic nerve increases endo- and epineurial tumor necrosis factor-alpha protein. Neurosci Lett (2004) 1.14
Additive effects of serotonin transporter and tryptophan hydroxylase-2 gene variation on emotional processing. Cereb Cortex (2006) 1.14
Emotional, physical, and sexual abuse in fibromyalgia syndrome: a systematic review with meta-analysis. Arthritis Care Res (Hoboken) (2011) 1.14
Autonomy of autonomic dysfunction in major depression. Psychosom Med (2009) 1.13
Early cytokine expression in mouse sciatic nerve after chronic constriction nerve injury depends on calpain. Brain Behav Immun (2007) 1.13
Pentoxifylline attenuates nociceptive sensitization and cytokine expression in a tibia fracture rat model of complex regional pain syndrome. Eur J Pain (2008) 1.13
Cutaneous neuropathy in Parkinson's disease: a window into brain pathology. Acta Neuropathol (2014) 1.12
Neurogenesis and schizophrenia: dividing neurons in a divided mind? Eur Arch Psychiatry Clin Neurosci (2007) 1.12
Diagnostic validity of epidermal nerve fiber densities in painful sensory neuropathies. Muscle Nerve (2008) 1.12
Polygenic transmission and complex neuro developmental network for attention deficit hyperactivity disorder: genome-wide association study of both common and rare variants. Am J Med Genet B Neuropsychiatr Genet (2013) 1.11
TNF signaling contributes to the development of nociceptive sensitization in a tibia fracture model of complex regional pain syndrome type I. Pain (2007) 1.11
Early diagnosis of peripheral nervous system involvement in Fabry disease and treatment of neuropathic pain: the report of an expert panel. BMC Neurol (2011) 1.11
High loading of polygenic risk for ADHD in children with comorbid aggression. Am J Psychiatry (2013) 1.10
Genome-wide association study in German patients with attention deficit/hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet (2011) 1.09
Increased pain sensitivity in alcohol withdrawal syndrome. Eur J Pain (2009) 1.09
Anterograde transport of tumor necrosis factor-alpha in the intact and injured rat sciatic nerve. J Neurosci (2002) 1.08
Objective evidence that small-fiber polyneuropathy underlies some illnesses currently labeled as fibromyalgia. Pain (2013) 1.08
Physiological properties of spinal lamina II GABAergic neurons in mice following peripheral nerve injury. J Physiol (2006) 1.08
Cross-disorder analysis of bipolar risk genes: further evidence of DGKH as a risk gene for bipolar disorder, but also unipolar depression and adult ADHD. Neuropsychopharmacology (2011) 1.07
Patients with Fabry disease after enzyme replacement therapy dose reduction versus treatment switch. J Am Soc Nephrol (2014) 1.07
Cytokine regulation in animal models of neuropathic pain and in human diseases. Neurosci Lett (2008) 1.06
Differences in inflammatory pain in nNOS-, iNOS- and eNOS-deficient mice. Eur J Pain (2007) 1.05
Absence of thermal hyperalgesia in serotonin transporter-deficient mice. J Neurosci (2003) 1.05
Co-morbidity of adult attention-deficit/hyperactivity disorder with focus on personality traits and related disorders in a tertiary referral center. Eur Arch Psychiatry Clin Neurosci (2007) 1.04
Management of fibromyalgia syndrome--an interdisciplinary evidence-based guideline. Ger Med Sci (2008) 1.03
Calcium-dependent assembly of centrin-G-protein complex in photoreceptor cells. Mol Cell Biol (2002) 1.03
Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia syndrome. Cochrane Database Syst Rev (2013) 1.03
Tryptophan hydroxylase-2 gene variation influences personality traits and disorders related to emotional dysregulation. Int J Neuropsychopharmacol (2006) 1.02
Transient receptor potential channel polymorphisms are associated with the somatosensory function in neuropathic pain patients. PLoS One (2011) 1.02
Sodium channel Na(v)1.7 is essential for lowering heat pain threshold after burn injury. J Neurosci (2012) 1.02
Musculoskeletal pain in patients with myotonic dystrophy type 2. Arch Neurol (2004) 1.02
Cyclooxygenase inhibition in nerve-injury- and TNF-induced hyperalgesia in the rat. Exp Neurol (2004) 1.01
Anxiety-related traits in mice with modified genes of the serotonergic pathway. Eur J Pharmacol (2003) 1.00
Differential effect of endothelial nitric oxide synthase (NOS-III) on the regulation of adult neurogenesis and behaviour. Eur J Neurosci (2004) 1.00
Modulation of behavioural profile and stress response by 5-HTT genotype and social experience in adulthood. Behav Brain Res (2009) 1.00
Efficacy and safety of Privigen(®) in patients with chronic inflammatory demyelinating polyneuropathy: results of a prospective, single-arm, open-label Phase III study (the PRIMA study). J Peripher Nerv Syst (2013) 1.00
The role of antidepressants in the management of fibromyalgia syndrome: a systematic review and meta-analysis. CNS Drugs (2012) 1.00
Antidepressant drugs transactivate TrkB neurotrophin receptors in the adult rodent brain independently of BDNF and monoamine transporter blockade. PLoS One (2011) 0.99
A systematic review on the effectiveness of treatment with antidepressants in fibromyalgia syndrome. Arthritis Rheum (2008) 0.98
The International Consortium on Lithium Genetics (ConLiGen): an initiative by the NIMH and IGSLI to study the genetic basis of response to lithium treatment. Neuropsychobiology (2010) 0.98
Tumor necrosis factor receptor 1 and 2 proteins are differentially regulated during Wallerian degeneration of mouse sciatic nerve. Exp Neurol (2005) 0.97
Serotonergic modulation in executive functioning: linking genetic variations to working memory performance. Neuropsychologia (2011) 0.97
Impact of the ADHD-susceptibility gene CDH13 on development and function of brain networks. Eur Neuropsychopharmacol (2012) 0.96
Review of pharmacological therapies in fibromyalgia syndrome. Arthritis Res Ther (2014) 0.96